Limitations of widely used high-risk human papillomavirus laboratory-developed testing in cervical cancer screening

References

• WrightTCJrCoxJTMassadLS2001 Consensus Guidelines for the management of women with cervical cytological abnormalitiesJAMA2002287162120212911966387
   PubMed Web of Science ®Google Scholar
• US Food and Drug AdministrationFDA news: FDA approves expanded use of HPV test. FDA News3312003 Available from: http://www.fda.gov/ohrms/dockets/dockets/07p0210/07p-0210-ccp0001-01-FDA-News-vol3.pdf. Accessed August 9, 2012.
   Google Scholar
• SaslowDSolomonDLawsonHWAmerican Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancerAm J Clin Pathol2012137451654222431528
   PubMed Web of Science ®Google Scholar
• VanceGHCollege of American Pathologists proposal for the oversight of laboratory-developed testsArch Pathol Lab Med2011135111432143522032569
   PubMed Web of Science ®Google Scholar
• ClavelCMasureMPutaudIHybrid Capture II, a new sensitive test for human papillomavirus detection. Comparison with Hybrid Capture I and PCR results in cervical lesionsJ Clin Pathol1998511073774010023335
   PubMed Web of Science ®Google Scholar
• SiddiquiMTCohenCNassarADetecting high-grade cervical disease on ASC-H cytology: role of BD ProEx C and digene Hybrid Capture II HPV DNA testingAm J Clin Pathol2008130576577018854269
   PubMed Web of Science ®Google Scholar
• KoVTambouretRHKueblerDLBlack-SchafferWSWilburDCHuman papillomavirus testing using Hybrid Capture II with SurePath collection: initial evaluation and longitudinal data provide clinical validation for this methodCancer2006108646847417091508
   PubMed Web of Science ®Google Scholar
• TriPath ImagingComments on the FDA review of Digene’s PMA application [press release]Burlington, NCTriPath Imaging7102002
   Google Scholar
• KupferCLindebaumKGilesJChendvankarRLeeYSprenger-HausselsMQIAsymphony AXpH sample preparation for automated conversion of liquid-based cytology specimens for use in the digene HC2 high-risk HPV DNA testPaper presented at: EUROGIN 2011 CongressMay 8–11, 2011Lisbon, Portugal
   Google Scholar
• BelinsonJLWuRBelinsonSEA population-based clinical trial comparing endocervical high-risk HPV testing using Hybrid Capture 2 and Cervista from the SHENCAST II studyAm J Clin Pathol2011135579079521502436
   PubMed Web of Science ®Google Scholar
• StolerMHWrightTCJrSharmaAThe interplay of age stratification and HPV testing on the predictive value of ASC-US cytologyAm J Clin Pathol2012137229530322261457
   PubMed Web of Science ®Google Scholar
• RatnamSCoutleeFFontaineDAptima HPV E6/E7 mRNA test is as sensitive as Hybrid Capture 2 assay but more specific at detecting cervical precancer and cancerJ Clin Microbiol201149255756421147950
   PubMed Web of Science ®Google Scholar
• BoschFXLorinczAMunozNMeijerCJShahKVThe causal relation between human papillomavirus and cervical cancerJ Clin Pathol200255424426511919208
   PubMed Web of Science ®Google Scholar
• BouvardVBaanRStraifKA review of human carcinogens – part B: biological agentsLancet Oncol200910432132219350698
   PubMed Web of Science ®Google Scholar
• FerrisRLMartinezISirianniNHuman papillomavirus-16 associated squamous cell carcinoma of the head and neck (SCCHN): a natural disease model provides insights into viral carcinogenesisEur J Cancer200541580781515763658
   PubMed Web of Science ®Google Scholar
• KinneyWFettermanBCoxJTLoreyTFlanaganTCastlePECharacteristics of 44 cervical cancers diagnosed following Pap-negative, high risk HPV-positive screening in routine clinical practiceGynecol Oncol2011121230931321276605
   PubMed Web of Science ®Google Scholar
• KangWDKimCHCoMKComparison of Hybrid Capture II assay with the human papillomavirus DNA chip test for the detection of high-grade cervical lesionsInt J Gynecol Cancer200919592492819574786
   PubMed Web of Science ®Google Scholar
• ShermanMESchiffmanMCoxJTEffects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS)J Natl Cancer Inst200294210210711792748
   PubMedGoogle Scholar
• KinneyWStolerMHCastlePESpecial commentary: patient safety and the next generation of HPV testsAm J Clin Pathol2010135219319920660320
   PubMed Web of Science ®Google Scholar
• RoncoGGiorgi-RossiPCarozziFResults at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening testJ Natl Cancer Inst2008100749250118364502
   PubMedGoogle Scholar
• BouletGABenoyIHDepuydtCEHuman papillomavirus 16 load and E2/E6 ratio in HPV16-positive women: biomarkers for cervical intraepithelial neoplasia ≥2 in a liquid-based cytology settingCancer Epidemiol Biomarkers Prev200918112992299919861526
   PubMed Web of Science ®Google Scholar
• KatkiHAKinneyWKFettermanBCervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practiceLancet Oncol201112766367221684207
   PubMed Web of Science ®Google Scholar
• LiZAustinRMGuoMZhaoCScreening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinomaArch Pathol Lab Med8202012 [Epub ahead of print.]
   Web of Science ®Google Scholar
• MoelansCBOostenrijkDMoonsMJvan DiestPJFormaldehyde substitute fixatives: effects on nucleic acid preservationJ Clin Pathol2011641196096721715573
   PubMed Web of Science ®Google Scholar
• CuschieriKSBeattieGHassanSRobertsonKCubieHAssessment of human papillomavirus mRNA detection over time in cervical specimens collected in liquid based cytology mediumJ Virol Methods20051241–221121515664071
   PubMed Web of Science ®Google Scholar
• LinWMAshfaqRMichalopoulosEAMaitraAGazdarAFMullerCYMolecular Papanicolaou tests in the twenty-first century: molecular analyses with fluid-based Papanicolaou technologyAm J Obstet Gynecol20001831394510920306
   PubMed Web of Science ®Google Scholar
• PowellNSmithKFianderARecovery of human papillomavirus nucleic acids from liquid-based cytology mediaJ Virol Methods20061371586216828171
   PubMed Web of Science ®Google Scholar
• ArbynMAnderssonKBergeronCBogersJPvon Knebel-DoebertitzMDillnerJCervical cytology biobanks as a resource for molecular epidemiologyMethods in Mol Biol201167527929820949396
   PubMedGoogle Scholar
• SurePath^® collection [package insert]Franklin Lakes, NJBecton, Dickinson and Company2011
   Google Scholar
• AnekellaBDrygaSMoskowitzKStability of integrated HPV16 DNA in various sample transport mediaJ Mol Diagn20079679680
   Web of Science ®Google Scholar
• SeraCare Life Sciences, Inc. ACCURUN® 372 series 400 HPV DNA positive control. Available from: http://www.seracarecatalog.com/Default.aspx?tabid=219&txtSearch=A3&List=1&SortField=ProductName%2CProductName&ProductID=121#LiveContent[ACC-P]. Accessed July 16, 2012.
   Google Scholar
• MoriartyATBentzJSWinklerBProficiency testing of high risk human papillomavirus DNA tests: the first 3 years of experience of the College of Pathologists CHPV surveysArch Pathol Lab Med Forthcoming 2012.
   Google Scholar
• Davis-DevineSDaySJFreundGGTest performance comparison of inform HPV and Hybrid Capture 2 high-risk DNA test using the SurePath liquid-based Pap test as the collection methodAm J Clin Pathol20051241243015923167
   PubMed Web of Science ®Google Scholar
• SiddiqiASpataroMMcIntireHHybrid capture 2 human papillomavirus DNA testing for women with atypical squamous cells of undetermined significance Papanicolaou results in SurePath and ThinPrep specimensCancer2009117531832519693966
   PubMed Web of Science ®Google Scholar
• ZhaoFHHuSYBianJJComparison of ThinPrep and SurePath liquid-based cytology and subsequent human papillomavirus DNA testing in ChinaCancer Cytopathol2011119638739421774094
   PubMed Web of Science ®Google Scholar
• KellyRSPatnickJKitchenerHCMossSMHPV testing as a triage for borderline or mild dyskaryosis on cervical cytology: results from the Sentinel Sites studyBr J Cancer2011105798398821897395
   PubMed Web of Science ®Google Scholar
• StolerMHCastlePESolomonDSchiffmanMThe expanded use of HPV testing in gynecologic practice per ASCCP-guided management requires the use of well-validated assaysAm J Clin Pathol2007127333533717276947
   PubMed Web of Science ®Google Scholar
• NaryshkinSAustinRMLimitations of widely used high risk HPV DNA testing in patients with invasive cervical cancerPaper presented at: EUROGIN 2011 CongressMay 8–11, 2011Lisbon, Portugal
   Google Scholar